February 15, 2021

 

Oil-Dri announces patent in South Korea for novel mineral-based feed additive
 

 

Oil-Dri Corporation of America, which conducts business as Amlan International, announced on February 11 that the South Korean Intellectual Property Office has issued Patent 1021882090000 entitled "Clay Product and Uses Thereof", which protects the proprietary mineral-based technology of Amlan's natural feed additives Varium^® (for poultry) and NeoPrime^® (for swine).

 

Both products help global producers to meet consumer demands for high-quality antibiotic-free animal protein.

 

The patent provides a methodology for using a natural, mineral-based formulation to mitigate the effects of exposure to pathogenic bacteria and the disease-causing toxins they produce, which damage gut health and function. Amlan's mineral is specifically selected for its chemical composition to allow for optimal thermal activation, a proprietary process that is tailored to optimise the binding capacity of each product.

 

Varium and NeoPrime are performance feed additives that promote intestinal health and function and can replace the need for in-feed antibiotic growth promoters.

 

Advancements in feed additive research and formulation are helping to transform animal protein production by providing proven and reliable alternatives to in-feed antibiotics used to promote growth and productivity. Last year, the United States and the European Union issued similar patents for the formulation featured in Varium and NeoPrime.

 

China issued a similar patent in 2018.

 

"Feedback on Varium from poultry integrators has been incredibly positive and recognised by many, including Fox Business Network's Innovation Nation series," said Dan Jaffee, president and CEO of Oil-Dri Corporation of America, and president and general manager of Amlan. "Reports show poultry producers who incorporate Varium into their poultry production are able to improve the feed conversion rates and grow healthier birds that are less stressed and have increased the marketability of their products through improved skin, liver and feet quality.

 

"The Korean patent is yet another example of Amlan's commitment to provide the global market with reliable mineral-based feed additives that can be a value-add to antibiotic-free production."

 

Unlike antibiotics, Amlan's patented technology includes a synergistic formula of three ingredients with distinct modes of action: a surface-activated mineral that facilitates chemical binding of pathogenic intestinal bacteria and the disease-causing toxins they produce; an immunomodulator that stimulates an animal's innate immune system to naturally defend against disease; and an energy source for the replenishment of intestinal epithelial cells that is essential for healthy gut function.

 

With the inclusion of the technology in animal feed, producers have effectively eliminated the use of antibiotics to promote growth and have experienced equivalent or better outcomes, Amlan said.

 

- Amlan